Dallas Drugs Private Limited

Dallas Drugs Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U15400CH2012PTC033748 Incorporated 25 April 2012 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹12.01 Cr
▲ 138% YoY
Net profit · FY 2025
₹19.62 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹2.69 Cr
EBITDA margin 22.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹7.46 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
16
Provident fund records

About Dallas Drugs Private Limited

Data last updated:

Dallas Drugs Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U15400CH2012PTC033748. Its GSTIN is 02AABCF9584E2ZO (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3 Cr. It was formerly known as Friska Foods Private Limited. It is led by directors Rajesh Gupta and Anil Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO No. 805 1st Floor (Half Portion At 1st Floor) N.A.C Manimajra, Chandigarh, India – 160002.

As per the financials filed for FY 2025, the company reported a revenue of ₹12.01 Cr, a growth of 138% compared to the previous year. For the same year it recorded a net profit of ₹19.62 Lakh (net margin 1.6%) and EBITDA of ₹2.69 Cr (EBITDA margin 22.4%). Revenue has grown at a compounded annual rate (CAGR) of 112% over five years.

The company has about 16 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Dallas Drugs. As per MCA filings, the company has open charges of ₹7.46 Cr on record.

Dallas Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002235). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dallasdrugs.org.

Company details

CIN U15400CH2012PTC033748
Registration Number 033748
Incorporation Date 25 April 2012
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0002235

Recognitions & Rankings of Dallas Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-HP-11-0002235

Contact details

Dallas Drugs Private Limited's registered office is in Chandigarh, Chandigarh. Its website is dallasdrugs.org. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    SCO No. 805 1st Floor (Half Portion At 1st Floor) N.A.C Manimajra, Chandigarh, India – 160002
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dallas Drugs Private Limited, buy the company report.

Comprehensive company report
Dallas Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Dallas Drugs operates one associated brand: Dallas Drugs. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing of pharmaceutical tablets and capsules for domestic and export markets in the healthcare sector.dallasdrugs.org

Business activity

The main business activity of Dallas Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Dallas Drugs Private Limited, buy the company report.

Financials of Dallas Drugs Private Limited

FY 2025 filings available

Dallas Drugs Private Limited reported revenue of ₹12.01 Cr (up 138% YoY) for FY 2025.

Revenue · FY 2025
₹12.01 Cr ▲ 138%
Net profit · FY 2025
₹19.62 Lakh margin 1.6%
EBITDA · FY 2025
₹2.69 Cr margin 22.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 138%
5 years · compounded
▲ 112%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 18%
5 years · compounded
▲ 214%

Revenue has grown at a compounded annual rate (CAGR) of 112% over five years, including 138% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.69 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹19.62 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin22.4%
Net Profit Margin1.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dallas Drugs Private Limited, buy the company report.

Board of directors of Dallas Drugs Private Limited

Dallas Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajesh GuptaDirector29 Sep 20188 Years 1 MonthsCurrent
Anil KumarDirector29 Sep 20188 Years 1 MonthsCurrent

Peer comparison

Dallas Drugs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Hilsun Foods and Drugs Private Limited₹12.06 Cr (FY 2024)29.0%Thane, Maharashtra, India
Ainesh Pharma Private Limited₹12.05 Cr (FY 2025)-10.0%Vijayawada, Andhra Pradesh, India
Ardor Drugs Private Limited₹12.04 Cr (FY 2025)-33.0%Surat, Gujarat, India
Dallas Drugs Private Limitedthis company₹12.01 Cr (FY 2025)₹19.62 Lakh1.6%138.0%16Chandigarh, India
T'walker's Pharmaceuticals Private Limited₹12 Cr (FY 2024)21.0%Pune, Maharashtra, India
Samay Pharma India Private Limited₹11.93 Cr (FY 2025)2.0%Delhi, India

To see the full peer comparison of Dallas Drugs Private Limited, buy the company report.

Auditor

Dallas Drugs Private Limited is audited by Nerkar & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Nerkar & Co.FY 2024021335C

Shareholding

The shareholding of Dallas Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dallas Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.46 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹7.46 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Apr 2019100268414State Bank of India₹7.46 CrOpen

To see the full charge records of Dallas Drugs Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dallas Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Dallas Drugs Private Limited has a workforce of 16 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
16
Active EPFO establishments
1
Employee growth
-40.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2716
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20

To see the full employee and EPFO history of Dallas Drugs Private Limited, buy the company report.

GST

Dallas Drugs has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
02AABCF9584E2ZOHimachal PradeshActive10 Jan 2019

To see the full GST registrations and return filing status of Dallas Drugs Private Limited, buy the company report.

Recent activity

Dallas Drugs Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Amrinder Singh Sidhu ceased to be Director on 26 Oct 2018.

Charges
A charge with State Bank Of India of Rs. 7.46 Cr registered on 20 Apr 2019 with Charge ID 100268414 was modified on 30 May 2026.
AGM
Dallas Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dallas Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with State Bank Of India amounted to Rs. 7.46 Cr with Charge ID 100268414 was registered on 20 Apr 2019.
Ceased
Amrinder Singh Sidhu ceased to be Director.
Ceased
Pukhraj Sidhu ceased to be Director.
Appointed
Anil Kumar was appointed as Director.
Appointed
Rajesh Gupta was appointed as Director.
Incorporation
25 Apr 2012
Dallas Drugs Private Limited was registered on 25 Apr 2012 with Roc Chandigarh & aged 14 years 6 months as per MCA records.

Frequently asked questions

Dallas Drugs is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2012 (14+ years old) and is registered under CIN U15400CH2012PTC033748.

Dallas Drugs has 2 current directors:

The latest financial statements of Dallas Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Dallas Drugs is 02AABCF9584E2ZO, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Dallas Drugs is U15400CH2012PTC033748. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dallas Drugs was incorporated on 25 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Dallas Drugs by revenue are Hilsun Foods and Drugs Private Limited, Ainesh Pharma Private Limited, Ardor Drugs Private Limited, T'walker's Pharmaceuticals Private Limited, Samay Pharma India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Amrinder Singh Sidhu ceased to be Director on 26 Oct 2018. Pukhraj Sidhu ceased to be Director on 02 Oct 2018. Anil Kumar was appointed as Director on 29 Sep 2018. Dallas Drugs has 4 board changes on record in total.

Yes, Dallas Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0002235).

Dallas Drugs can be reached through the website dallasdrugs.org. Its registered office is in Chandigarh, India.

The registered office of Dallas Drugs is at SCO No. 805 1st Floor Half Portion At 1st Floor N.A.C Manimajra, Chandigarh, India – 160002.